Clinical Implications of Thrombocytopenia for the Cirrhotic Patient

References

• Hayashi H, Beppu T, Shirabe K, et al. Management of thrombocytopenia due to liver cirrhosis: a review. World J Gastroenterol. 2014;20(10):2595–2605. doi:10.3748/wjg.v20.i10.259524627595
   PubMed Web of Science ®Google Scholar
• Mitchell O, Feldman DM, Diakow M, et al. The pathophysiology of thrombocytopenia in chronic liver disease. Hep Med. 2016;8:39–50.
   PubMed Web of Science ®Google Scholar
• Basili S, Raparelli V, Violi F. The coagulopathy of chronic liver disease: is there a causal relationship with bleeding? Yes. Eur J Intern Med. 2010;21(2):62–64. doi:10.1016/j.ejim.2010.01.00520206871
   PubMed Web of Science ®Google Scholar
• Giannini EG, Moscatelli A, Brunacci M, et al. Prognostic role of mean platelet volume in patients with cirrhosis. Dig Liver Dis. 2016;48(4):409–413. doi:10.1016/j.dld.2015.10.01826699823
   PubMedGoogle Scholar
• Chin JL, Hisamuddin SH, O’Sullivan A, et al. Thrombocytopenia, platelet transfusion, and outcome following liver transplantation. Clin Appl Thromb Hemost. 2016;22(4):351–360. doi:10.1177/107602961455977125430936
   PubMed Web of Science ®Google Scholar
• Kurokawa T, Ohkohchi N. Platelets in liver disease, cancer and regeneration. World J Gastroenterol. 2017;23(18):3228–3239. doi:10.3748/wjg.v23.i18.322828566882
   PubMed Web of Science ®Google Scholar
• Deng H, Qi X, Guo X. Diagnostic accuracy of APRI, AAR, FIB-4, FI, King, Lok, Forns and FibroIndex scores in predicting the presence of esophageal varices in liver cirrhosis. Medicine. 2015;94(42):e1795. doi:10.1097/MD.000000000000179526496312
   PubMed Web of Science ®Google Scholar
• Weksler BB. Review article: the pathophysiology of thrombocytopenia in hepatitis C virus infection and chronic liver disease. Aliment Pharmacol Ther. 2007;26:13–19. doi:10.1111/j.1365-2036.2007.03512.x
   PubMed Web of Science ®Google Scholar
• Giannini E, Borro P, Botta F, et al. Serum thrombopoietin levels are linked to liver function in untreated patients with hepatitis C virus-related chronic hepatitis. J Hepatol. 2002;37(5):572. doi:10.1016/S0168-8278(02)00274-X12399221
   PubMed Web of Science ®Google Scholar
• Lin Z-H, Xin Y-N, Dong Q-J, et al. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology. 2011;53(3):726–736. doi:10.1002/hep.2410521319189
   PubMed Web of Science ®Google Scholar
• Garcia-Tsao G, Abraldes JG, Berzigotti A, et al. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2017;65(1):310–335. doi:10.1002/hep.v65.127786365
   PubMed Web of Science ®Google Scholar
• Sarangapani A, Shanmugam C, Kalyanasundaram M, et al. Noninvasive prediction of large esophageal varices in chronic liver disease patients. Saudi J Gastroenterol. 2010;16(1):38–42. doi:10.4103/1319-3767.5876720065573
   PubMedGoogle Scholar
• Barrera F, Zuniga P, Arrese M. Prediction of esophageal variceal bleeding in liver cirrhosis: is there a role for hemostatic factors? Semin Thromb Hemost. 2015;41(05):481–487. doi:10.1055/s-0000007726049066
   PubMed Web of Science ®Google Scholar
• Colli A, Gana JC, Yap J, et al. Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of esophageal varices in people with chronic liver disease or portal vein thrombosis. Cochrane Database Sys Rev. 2017;4:1–210.
   Google Scholar
• Madonia S, D’Amino G, Traina M, et al. Prognostic indicators of successful endoscopic sclerotherapy for prevention of rebleeding from oesophageal varices in cirrhosis: a long-term cohort study. Dig Liver Dis. 2000;32(9):782–791. doi:10.1016/S1590-8658(00)80356-411215559
   PubMedGoogle Scholar
• Sebastiani G, Tempesta D, Fattovich G, et al. Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: results of a multicenter, large-scale study. J Hepatol. 2010;53(4):630–638. doi:10.1016/j.jhep.2010.04.01920615567
   PubMed Web of Science ®Google Scholar
• Zambam de Mattos A, Alves de Mattos A, Daros LF, et al. Aspartate aminotransferase-to-platelet ratio index (APRI) for the non-invasive prediction of esophageal varices. Ann Hepatol. 2013;12(5):810–814. doi:10.1016/S1665-2681(19)31324-924018500
   PubMed Web of Science ®Google Scholar
• Hassan EM, Omran DA, El Beshlawey ML, et al. Can transient elastography, Fib-4, Forns index, and Lok score predict esophageal varices in HCV-related cirrhotic patients? Gastroenterol Hepatol. 2014;37(2):58–65. doi:10.1016/j.gastrohep.2013.09.00824365388
   PubMed Web of Science ®Google Scholar
• Burton JR, Liangpunsakul S, Lapidus J, et al. Validation of a multivariate model predicting presence and size of varices. J Clin Gastroenterol. 2007;41(6):609–615. doi:10.1097/01.mcg.0000225669.84099.0417577118
   PubMed Web of Science ®Google Scholar
• Abraldes JG, Bureau C, Stefanescu H, et al. Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: the “Anticipate” study. Hepatology. 2016;64(6):2173–2184. doi:10.1002/hep.v64.627639071
   PubMed Web of Science ®Google Scholar
• de Franchis R, Baveno VI Faculty. Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63(3):743–752. doi:10.1016/j.jhep.2015.05.022.26047908
   PubMed Web of Science ®Google Scholar
• Merli M, Nicolini G, Angeloni S, et al. Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol. 2003;38(3):266–272. doi:10.1016/S0168-8278(02)00420-812586291
   PubMed Web of Science ®Google Scholar
• Vanbiervliet G, Giudicelli-Bornard S, Piche T, et al. Predictive factors of bleeding related to post-banding ulcer following endoscopic variceal ligation in cirrhotic patients: a case-control study. Aliment Pharmacol Ther. 2010;32:225–232. doi:10.1111/j.1365-2036.2010.04331.x20412065
   PubMed Web of Science ®Google Scholar
• Wehmeyer MH, Krohm S, Kastein F, et al. Prediction of spontaneous bacterial peritonitis in cirrhotic ascites by a simple scoring system. Scand J Gastroenterol. 2014;49(5):595–603. doi:10.3109/00365521.2013.84847124673156
   PubMed Web of Science ®Google Scholar
• Angeli P, Bernardi M, Laleman W, et al. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406–460. doi:10.1016/j.jhep.2018.03.02429653741
   PubMed Web of Science ®Google Scholar
• Kumada T, Toyoda H, Kiriyama S, et al. Incidence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection who have normal alanine aminotransferase values. J Med Virol. 2010;82(4):539–545. doi:10.1002/jmv.2168620166172
   PubMed Web of Science ®Google Scholar
• Kawamura Y, Arase Y, Ikeda K, et al. Large-scale long-term follow-up study of Japanese patients with non-alcoholic fatty liver disease for the onset of hepatocellular carcinoma. Am J Gastroenterol. 2012;107(2):253–261. doi:10.1038/ajg.2011.32722008893
   PubMed Web of Science ®Google Scholar
• Carr BI, Guerra V, De Giorgio M, et al. Small hepatocellular carcinomas and thrombocytopenia. Oncology. 2012;83:331–338. doi:10.1159/00034153323006906
   PubMed Web of Science ®Google Scholar
• Carr BI, Guerra V. Thrombocytosis and hepatocellular carcinoma. Dig Dis Sci. 2013;58(6):1790–1796. doi:10.1007/s10620-012-2527-323314854
   PubMed Web of Science ®Google Scholar
• Sturesson C, Hoekstra L, Andersson R, et al. Importance of thrombocytes for the hypertrophy response after portal vein embolization. Hepatogastroenterology. 2015;62(137):98–101.25911876
   PubMedGoogle Scholar
• Riediger C, Bachmann J, Hapfelmeier A, et al. Low postoperative platelet count is associated with negative outcome after liver resection for hepatocellular carcinoma. Hepatogastroenterology. 2014;61(133):1313–1320.25436303
   PubMedGoogle Scholar
• Wang H-Q, Yang J, Yang J-Y, et al. Low immediate postoperative platelet count is associated with hepatic insufficiency after hepatectomy. World J Gastroenterol. 2014;20(33):11871–11877. doi:10.3748/wjg.v20.i33.1187125206294
   PubMed Web of Science ®Google Scholar
• Golriz M, Ghamamejad O, Khajeh E, et al. Preoperative thrombocytopenia may predict poor surgical outcome after extended hepatectomy. CJGH. 2018:1275720. doi:10.1155/2018/1275720
   Google Scholar
• Li L, Wang H, Yang J, et al. Immediate postoperative low platelet counts after living donor liver transplantation predict early allograft dysfunction. Medicine. 2015;94(34):1–7.
   Web of Science ®Google Scholar
• Lesurtel M, Raptis DA, Melloul E, et al. Low platelet counts after liver transplantation predict early posttransplant survival: the 60-5 criterion. Liver Transpl. 2014;20(2):147–155. doi:10.1002/lt.v20.224123804
   PubMed Web of Science ®Google Scholar
• Bleibel W, Caldwell SH, Curry MP, et al. Peripheral platelet count correlates with liver atrophy and predicts long-term mortality on the liver transplant waiting list. Transpl Int. 2013;26(4):435–442. doi:10.1111/tri.1206423356587
   PubMed Web of Science ®Google Scholar
• Witters P, Freson K, Verslype C, et al. Review article: blood platelet number and function in chronic liver disease and cirrhosis. Aliment Pharmacol Ther. 2008;27:1017–1029. doi:10.1111/j.1365-2036.2008.03674.x18331464
   PubMed Web of Science ®Google Scholar
• Zucker ML, Hagedorn CH, Murphy CA, et al. Mechanism of thrombocytopenia in chronic hepatitis C as evaluated by the immature platelet function. Int J Lab Hematol. 2012;34:525–532. doi:10.1111/ijlh.2012.34.issue-522708981
   PubMed Web of Science ®Google Scholar
• Rauber P, Lammert F, Grotemeyer K, et al. Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: a cohort study. PLoS One. 2018;13(2):e0192271. doi:10.1371/journal.pone.019227129438423
   PubMed Web of Science ®Google Scholar
• Erdem MG, Cil EO, Tukek T, et al. Evaluation of platelet and mean platelet volume levels in patients with liver cirrhosis. Arch Clin Exp Med. 2018;3(1):18–21.
   Google Scholar
• Northup PG, Caldwell SH. Coagulation in liver disease: a guide for the clinician. Clin Gastroenterol Hepatol. 2013;11:1064–1074. doi:10.1016/j.cgh.2013.02.02623506859
   PubMed Web of Science ®Google Scholar
• Koganov ES, Carmichael SL, Forde EE, et al. Platelet function in thrombocytopenic patients with chronic liver disease. Blood. 2017;130(Suppl 1):2314.
   Google Scholar
• Rodriguez-Castro KI, Antonello A, Ferrarese A. Spontaneous bleeding or thrombosis in cirrhosis: what should be feared the most? World J Hepatol. 2015;7(14):1818–1827. doi:10.4254/wjh.v7.i14.181826207163
   PubMedGoogle Scholar
• Kalambokis GN, Oikonomou A, Christou L, et al. von Willebrand factor and procoagulant imbalance predict outcome in patients with cirrhosis and thrombocytopenia. J Hepatol. 2016;65:921–928. doi:10.1016/j.jhep.2016.06.00227297911
   PubMed Web of Science ®Google Scholar
• Sogaard KK, Horvath-Puho E, Gronbaek H, et al. Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study. Am J Gastro. 2009;104:96–101. doi:10.1038/ajg.2008.34
   PubMed Web of Science ®Google Scholar
• Ambrosino P, Tarantino L, Di Minno G, et al. The risk of venous thromboembolism in patients with cirrhosis. Thromb Haemost. 2017;117(1):139–148. doi:10.1160/TH16-06-045027761574
   PubMed Web of Science ®Google Scholar
• Barba R, Gonzalvez-Garsch A, Joya Seijo D, et al. Venous thromboembolism in patients with liver diseases. J Thromb Haemost. 2018;16:2003–2007. doi:10.1111/jth.1425530066476
   PubMed Web of Science ®Google Scholar
• Gulley D, Teal E, Suvannasankha A, et al. Deep vein thrombosis and pulmonary embolism in cirrhosis patients. Dig Dis Sci. 2008;53:3012–3017. doi:10.1007/s10620-008-0265-318443906
   PubMed Web of Science ®Google Scholar
• Dabbagh O, Oza A, Prakash S, et al. Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease. Chest. 2010;137:1145–1149. doi:10.1378/chest.09-217720040609
   PubMed Web of Science ®Google Scholar
• Stine JG, Niccum BA, Zimmet AN, et al. Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to non-alcoholic steatohepatitis. Clin Transl Gastroenterol. 2018;9(3):140.29511162
   PubMed Web of Science ®Google Scholar
• Northup PG, McMahon MM, Ruhl A, et al. Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism. Am J Gastroenterology. 2006;101(7):1524–1528. doi:10.1111/j.1572-0241.2006.00588.x
   PubMed Web of Science ®Google Scholar
• Noronha Ferreira C, Marinho RT, Cortez-Pinto H, et al. Incidence, predictive factors and clinical significance of development of portal vein thrombosis in cirrhosis: a prospective study. Liver Int. 2019;39:1459–1467. doi:10.1111/liv.1412131021512
   PubMed Web of Science ®Google Scholar
• Yang LS, Alukaidey S, Croucher K, Dowling D. Suboptimal use of pharmacological venous thromboembolism prophylaxis in cirrhotic patients. Intern Med J. 2018;48(9):1056–1063. doi:10.1111/imj.2018.48.issue-929468795
   PubMed Web of Science ®Google Scholar
• Tripodi A, Mannuccio PM. The coagulopathy of chronic liver disease. NEJM. 2011;365:147–156. doi:10.1056/NEJMra101117021751907
   PubMed Web of Science ®Google Scholar
• Mallett SV, Chowdary P, Burroughs AK. Clinical utility of viscoelastic tests of coagulation in patients with liver disease. Liver Int. 2013;33:961–974. doi:10.1111/liv.1215823638693
   PubMed Web of Science ®Google Scholar
• Siringo S, Burroughs AK, Bolondi L, et al. Peptic ulcer and its course in cirrhosis: an endoscopic and clinical prospective study. J Hepatology. 1995;22:633–641. doi:10.1016/0168-8278(95)80219-3
   PubMed Web of Science ®Google Scholar
• Hsu Y-C, Lin J-T, Chen -T-T, et al. Long-term risk of recurrent peptic ulcer bleeding in patients with liver cirrhosis: a 10-year nationwide cohort study. Hepatology. 2012;56(2):698–705. doi:10.1002/hep.2568422378148
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gonzalez J, Garcia-Compean D, Vazquez-Elizondo G, et al. Nonvariceal upper gastrointestinal bleeding in patients with liver cirrhosis. Clinical features, outcomes and predictors of in-hospital mortality. A prospective study. Ann Hepatol. 2011;10(3):287–295. doi:10.1016/S1665-2681(19)31540-621677330
   PubMed Web of Science ®Google Scholar
• Ardevol A, Ibanez-Sanz G, Profitos J, et al. Survival of patients with cirrhosis and acute peptic ulcer bleeding compared with variceal bleeding using current first-line therapies. Hepatology. 2018;67(4):1458–1471. doi:10.1002/hep.v67.428714072
   PubMed Web of Science ®Google Scholar
• Jimenez-Rosale R, Valverde-Lopez F, Vadillo-Calles F, et al. Inhospital and delayed mortality after upper gastrointestinal bleeding: an analysis of risk factors. Scand J Gastroenterol. 2018;53(6):714–720. doi:10.1080/00365521.2018.145450929575962
   PubMed Web of Science ®Google Scholar
• Ramos GP, Binder M, Hampel P, et al. Outcomes of endoscopic intervention for overt GI bleeding in severe thrombocytopenia. Gastrointest Endosc. 2018;88(1):55–61. doi:10.1016/j.gie.2018.01.02829408558
   PubMed Web of Science ®Google Scholar
• Madhwani R, Hanif FM, Ul Haque MM, et al. Noninvasive clinical predictors of portal hypertensive gastropathy in patients with liver cirrhosis. J Transpl Int Med. 2017;5(3):169–173. doi:10.1515/jtim-2017-0025
   Web of Science ®Google Scholar
• Primignani N, Carpinelli L, Preatoni P, et al. Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC). Gastroenterol. 2000;119(1):181–187.xs. doi:10.1053/gast.2000.8555
   PubMed Web of Science ®Google Scholar
• Camus M, Jensen DM, Mathews JD, et al. Epistaxis in end stage liver disease masquerading as severe upper gastrointestinal hemorrhage. World J Gastroenterol. 2014;20(38):13993–13998. doi:10.3748/wjg.v20.i38.1399325320538
   PubMed Web of Science ®Google Scholar
• Cohen O, Shoffel-Havakuk H, Warman M, et al. Early and late recurrent epistaxis admissions: patterns of incidence and risk factors. Oto Head Neck Surg. 2017;157(3):424–431. doi:10.1177/0194599817705619
   Web of Science ®Google Scholar
• Ferre AC, Nunez GL, Tellez VL, et al. Epistaxis in the cirrhotic patient: a complication to be considered. Gastroenterol Hepatol. 2019;42(1):11–15.30314764
   PubMed Web of Science ®Google Scholar
• Morgan J, Hinz EK. Conservative management of endometrial intraepithelial neoplasia in a patient with cirrhosis undergoing orthotopic liver transplant. Menopause. 2019;26:1068–1070. doi:10.1097/GME.000000000000134231453972
   PubMed Web of Science ®Google Scholar
• Hassan AA, Kroll MH. Acquired disorders of platelet function. Hematology Am Soc Hematol Educ Program. 2005;2005:403–408. doi:10.1182/asheducation-2005.1.403
   Google Scholar
• Nagata J, Hirose S, Shiraishi K, et al. Vaginal bleeding in a patient with type C liver cirrhosis without a past history of laparotomy: successful treatment with partial splenic artery embolization. Clin J Gastroenterol. 2012;5:275–281. doi:10.1007/s12328-012-0316-326182393
   PubMedGoogle Scholar
• Orlando G, Goffette P, Geubel A, et al. Vaginal bleeding complicating portal hypertension: a particular entity – report of two cases and review of the literature. Transplant Int. 2005;18:1382–1385. doi:10.1111/tri.2005.18.issue-12
   Web of Science ®Google Scholar
• Cundy TF, Butler J, Pope RM, et al. Amenorrhoea in women with non-alcoholic chronic liver disease. Gut. 1991;32:202–206. doi:10.1136/gut.32.2.2021864542
   PubMed Web of Science ®Google Scholar
• Rockey DC, Caldwell SH, Goodman ZD, et al. Liver biopsy. Hepatology. 2009;49(3):1017–1044. doi:10.1002/hep.2274219243014
   PubMed Web of Science ®Google Scholar
• Seeff LB, Everson GT, Morgan TR, et al. Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clin Gastroenterol Hepatol. 2010;8(10):877–883.20362695
   PubMed Web of Science ®Google Scholar
• Sharma P, McDonald GB, Banaji M. The risk of bleeding after percutaneous liver biopsy: relation to platelet count. J Clin Gastroenterol. 1982;4:451–453. doi:10.1097/00004836-198210000-000116960080
   PubMed Web of Science ®Google Scholar
• Kim KR, Ko G-Y, Sung K-B, et al. Transjugular liver biopsy in patients with living donor liver transplantation: comparison with percutaneous biopsy. Liver Transpl. 2008;14:971–979. doi:10.1002/lt.2144818581512
   PubMed Web of Science ®Google Scholar
• Wallace MJ, Narvios A, Lichtiger B, et al. Transjugular liver biopsy in patients with hematologic malignancy and severe thrombocytopenia. J Vasc Interv Radiol. 2003;14(3):323–327. doi:10.1097/01.RVI.0000058413.01661.b912631636
   PubMed Web of Science ®Google Scholar
• Petrasch F, Grothaus J, Mossner J, et al. Differences in bleeding behavior after endoscopic band ligation: a retrospective analysis. BMC Gastroenterol. 2010;10:5. doi:10.1186/1471-230X-10-520074379
   PubMed Web of Science ®Google Scholar
• Grothaus J, Petrasch F, Zeynalova S, et al. Risk factors for bleeding complications after endoscopic variceal ligation therapy. Z Gastroenterol. 2010;48(10):1200–1206. doi:10.1055/s-0029-124543520886424
   PubMed Web of Science ®Google Scholar
• Giannini EG, Giambruno E, Brunacci M, et al. Low fibrinogen levels are associated with bleeding after varices ligation in thrombocytopenic cirrhotic patients. Ann Hepatol. 2018;17(5):830–835. doi:10.5604/01.3001.0012.077530145561
   PubMed Web of Science ®Google Scholar
• Chen W-T, Lin C-Y, Sheen I-S, et al. MELD score can predict early mortality in patients with rebleeding after band ligation for variceal bleeding. World J Gastroenterol. 2011;17(16):2120–2125. doi:10.3748/wjg.v17.i16.212021547132
   PubMed Web of Science ®Google Scholar
• Viera da Rocha EC, D’Amico EA, Caldwell SH, et al. A prospective study of conventional and expanded coagulation indices in predicting ulcer bleeding after variceal band ligation. Clin Gastroenterol Hepatol. 2009;7:988–993. doi:10.1016/j.cgh.2009.04.01919410018
   PubMed Web of Science ®Google Scholar
• Reiberger T, Puspok A, Schoder M, et al. Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III). Wien Klin Wochemschr. 2017;129(Suppl 3):S135–S158. doi:10.1007/s00508-017-1262-3
   Web of Science ®Google Scholar
• De Gottardi A, Thevenot T, Spahr L, et al. Risk of complications after abdominal paracentesis in cirrhotic patients: a prospective study. Clin Gastroenterol Hepatol. 2009;7(8):906–909. doi:10.1016/j.cgh.2009.05.00419447197
   PubMed Web of Science ®Google Scholar
• Grabau CM, Crago SF, Hoff LK, et al. Performance standards for therapeutic abdominal paracentesis. Hepatology. 2004;40:484–488. doi:10.1002/hep.2031715368454
   PubMed Web of Science ®Google Scholar
• Pache I, Bilodeau M. Severe haemorrhage following abdominal paracentesis for ascites in patients with liver disease. Aliment Pharmacol Ther. 2005;21:525–529. doi:10.1111/j.1365-2036.2005.02387.x15740535
   PubMed Web of Science ®Google Scholar
• McVay PA, Toy PTCY. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion. 1991;31:164–171. doi:10.1046/j.1537-2995.1991.31291142949.x1996485
   PubMed Web of Science ®Google Scholar
• Mercaldi CJ, Lanes SF. Ultrasound guidance decreases complications and improves the cost of care among patients undergoing thoracentesis and paracentesis. Chest. 2013;143(2):532–538. doi:10.1378/chest.12-044723381318
   PubMed Web of Science ®Google Scholar
• Rowley MW, Agarwal S, Seetharam AB, et al. Real-time ultrasound-guided paracentesis by radiologists: near zero risk of hemorrhage without correction of coagulopathy. J Vasc Interv Radiol. 2019;30:259–264. doi:10.1016/j.jvir.2018.11.00130717961
   PubMed Web of Science ®Google Scholar
• Runyon BA. Introduction to the revised American association for the study of liver diseases practice guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology. 2013;57(4):1651–1680. doi:10.1002/hep.2635923463403
   PubMed Web of Science ®Google Scholar
• Valerin M, Napenas JJ, Brennan MT, et al. Modified child-pugh as a marker for postoperative bleeding from invasive dental procedures. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104(1):56–60. doi:10.1016/j.tripleo.2006.10.02517261376
   PubMed Web of Science ®Google Scholar
• Cocero N, Bezzi M, Martini S, et al. Oral surgical treatment of patients with chronic liver disease: assessments of bleeding and its relationship with thrombocytopenia and blood coagulation parameters. J Oral Maxillofac Surg. 2017;75(1):28–34. doi:10.1016/j.joms.2016.08.03327677683
   PubMed Web of Science ®Google Scholar
• Medina JB, Andrade NS, Eduardo FP, et al. Bleeding during and after dental extractions in patients with liver cirrhosis. Int J Oral Maxillofac Surg. 2018;47(12):1543–1549. doi:10.1016/j.ijom.2018.04.00729705406
   PubMed Web of Science ®Google Scholar
• Perdigao JP, Almeida PC, Rocha TD, et al. Postoperative bleeding after dental extraction in liver pretransplant patients. J Oral Maxillofac Surg. 2012;70(3):e177–e184. doi:10.1016/j.joms.2011.10.03322374059
   PubMed Web of Science ®Google Scholar
• Foster PF, Moore LR, Sankary HN, et al. Central venous catheterization in patients with coagulopathy. Arch Surg. 1992;127(3):273–275. doi:10.1001/archsurg.1992.014200300350061550472
   PubMedGoogle Scholar
• Estcourt LJ, Desborough M, Hopewell S, et al. Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia. Cochrane Database Syst Rev. 2016;12:CD011771. doi:10.1002/14651858.CD003091.pub4
   Web of Science ®Google Scholar
• Tercan F, Ozkan U, Oguzkurt L. US-guided placement of central vein catheters in patients with disorders of hemostasis. Eur J Radiol. 2008;65:253–256. doi:10.1016/j.ejrad.2007.04.00217482407
   PubMed Web of Science ®Google Scholar
• Zeidler K, Arn K, Senn O, et al. Optimal preprocedural platelet transfusion threshold for central venous catheter insertions in patients with thrombocytopenia. Transfusion. 2011;51(11):2269–2276. doi:10.1111/trf.2011.51.issue-1121517892
   PubMed Web of Science ®Google Scholar
• Shah A, Amarapurkar D, Dharod M, et al. Coagulopathy in cirrhosis: a prospective study to correlate conventional tests of coagulation and bleeding following invasive procedures in cirrhotics. Indian J Gastroenterol. 2015;34(5):359–364. doi:10.1007/s12664-015-0584-126487399
   PubMedGoogle Scholar
• Ray CE, Shenoy SS. Patients with thrombocytopenia: outcome of radiologic placement of central venous access devices. Radiology. 1997;204(1):97–99. doi:10.1148/radiology.204.1.92052289205228
   PubMed Web of Science ®Google Scholar
• Singh SA, Sharma S, Singh A, et al. The safety of ultrasound guided venous cannulation in patients with liver disease. Saudi J Anesthesia. 2015;9(2):155–160. doi:10.4103/1658-354X.152842
   Google Scholar
• Pandey CK, Saluja V, Gaurav K, et al. K time and maximum amplitude of thromboelastogram predict post-central venous cannulation bleeding in patients with cirrhosis: a pilot study. Indian J Med Res. 2017;145(1):184–189. doi:10.4103/ijmr.IJMR_749_14
   Web of Science ®Google Scholar
• Lisman T, Porte RJ. The role of platelets in liver inflammation and regeneration. Semin Thromb Hemost. 2010;36(02):170–174. doi:10.1055/s-0030-125150120414832
   PubMed Web of Science ®Google Scholar
• Matsuo R, Nakano Y, Ohkohchi N. Platelet administration via the portal vein promotes liver regeneration in rats after 70% hepatectomy. Ann Surg. 2011;253(4):759–763. doi:10.1097/SLA.0b013e318211caf821475016
   PubMed Web of Science ®Google Scholar
• Liu G, Xie C, Fang Y, et al. Splenectomy after partial hepatectomy accelerates liver regeneration in mice by promoting tight junction formation via polarity protein Par 2-aPKC. Life Sci. 2018;192:91–98. doi:10.1016/j.lfs.2017.11.03229166570
   PubMed Web of Science ®Google Scholar
• Maruyama T, Murata S, Takahashi K, et al. Platelet transfusion improves liver function in patients with chronic liver disease and cirrhosis. Tohoku J Exp Med. 2013;229(3):213–220. doi:10.1620/tjem.229.21323459612
   PubMed Web of Science ®Google Scholar
• Starlinger P, Haegele S, Offensperger F, et al. The profile of platelet αα-granule released molecules affects postoperative liver regeneration. Hepatology. 2016;63(5):1675–1688. doi:10.1002/hep.2833126528955
   PubMed Web of Science ®Google Scholar
• Myronovych A, Murata S, Chiba M, et al. Role of platelets on liver regeneration after 90% hepatectomy in mice. J Hepatol. 2008;49(3):363–372. doi:10.1016/j.jhep.2008.04.01918602717
   PubMed Web of Science ®Google Scholar
• Meyer J, Lejmi E, Fontana P, et al. A focus on the role of platelets in liver regeneration: do platelet-endothelial cell interactions initiate the regenerative process? J Hepatol. 2015;63(5):1263–1271. doi:10.1016/j.jhep.2015.07.00226169159
   PubMed Web of Science ®Google Scholar
• Minamino T, Ito Y, Ohkubo H, et al. Adhesion of platelets through thromboxane A2 receptor signaling facilitates liver repair during acute chemical-induced hepatotoxicity. Life Sci. 2015;132:85–92. doi:10.1016/j.lfs.2015.03.01525921763
   PubMed Web of Science ®Google Scholar
• Shido K, Chavez D, Cao Z, et al. Platelets prime hematopoietic-vascular niche to drive angiocrine-mediated liver regeneration. Signal Trans Targeted Ther. 2017;2(1):e16044. doi:10.1038/sigtrans.2016.44
   Web of Science ®Google Scholar
• Takahashi K, Kozuma Y, Suzuki H, et al. Human platelets promote liver regeneration with Kupffer cells in SCID mice. J Surg Res. 2013;180:62–72. doi:10.1016/j.jss.2012.11.03023260232
   PubMed Web of Science ®Google Scholar
• Groeneveld D, Pereyra D, Veldhuis Z, et al. Intrahepatic fibrin(ogen) deposition drives liver regeneration after partial hepatectomy in mice and humans. Blood. 2019;133(11):1245–1256. doi:10.1182/blood-2018-08-86905730655274
   PubMed Web of Science ®Google Scholar
• Murata S, Hashimoto I, Nakano Y, et al. Single administration of thrombopoietin prevents progression of liver fibrosis and promotes liver regeneration after partial hepatectomy in cirrhotic rats. Ann Surg. 2008;248(5):821–828. doi:10.1097/SLA.0b013e31818584c718948810
   PubMed Web of Science ®Google Scholar
• Kurokawa T, Murata S, Ohkohchi N. Stable liver function during long-term administration of eltrombopag, a thrombopoietin receptor agonist, in patients with chronic liver disease. Tohoku J Exp Med. 2016;240:277–279. doi:10.1620/tjem.240.27727928110
   PubMed Web of Science ®Google Scholar
• Kim J, Yi N-J, Shin WY, et al. Platelet transfusion can be related to liver regeneration after living donor liver transplantation. World J Surg. 2010;34:1052–1058. doi:10.1007/s00268-010-0464-x20151125
   PubMed Web of Science ®Google Scholar
• Han S, Ko JS, Gwak MS, et al. Association of platelet count and platelet transfusion with serotonin level during living donor liver transplantation: possible connection to graft regeneration. Transplant Proc. 2018;50(4):1104–1107. doi:10.1016/j.transproceed.2018.02.03529731075
   PubMed Web of Science ®Google Scholar
• Han S, Park H-W, Song JH, et al. Association between intraoperative platelet transfusion and early graft regeneration in living donor liver transplantation. Ann Surg. 2016;264(6):1065–1072. doi:10.1097/SLA.000000000000152626720430
   PubMed Web of Science ®Google Scholar